NCT03493295View on ClinicalTrials.gov

Non-interventional, Real Life Study on Satisfaction With LNG-IUS in Spanish Young Women (18-30 Years Old) With Different Parity Status and Menstrual Bleeding Pattern

CompletedOBSERVATIONAL
Enrollment

587

Participants

Timeline

Start Date

April 25, 2018

Primary Completion Date

November 30, 2020

Study Completion Date

March 15, 2021

Conditions
Contraception
Interventions
DRUG

Levonogestrel IntraUterine System (LNG-IUS)

At the routine clinical practice. Jaydess, Mirena, Kyleena Or any other levonogestrel intrauterine system (LNG-IUS) commercialized in Spain at the start of the study, only for contraception indication.

Trial Locations (1)

Unknown

Many locations, Multiple Locations

Sponsors

Lead Sponsor

Bayer
All Listed Sponsors
lead

Bayer

INDUSTRY

NCT03493295 - Non-interventional, Real Life Study on Satisfaction With LNG-IUS in Spanish Young Women (18-30 Years Old) With Different Parity Status and Menstrual Bleeding Pattern | Biotech Hunter | Biotech Hunter